Citations

Showing 10 of 108119 citations.

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Bartlett, Nancy L. , Wilson, Wyndham H. , Pederson, Levi , Polley, Mei‐Yin C. , Pitcher, Brandelyn N., Cheson, Bruce D. , Friedberg, Jonathan W. , Staudt, Louis M. , Wagner‐Johnston, Nina D. , Blum, Kristie A. , Reddy, Nishitha , Chang, Julie , Chadburn, Amy , Mathew, Susan , Fisher, Richard I., Richards, Kristy L. , Leonard, John P. , Bartlett, Nancy L , Jung, Sin‐Ho , Hsi, Eric D. , Maurer, Matthew J. , Kahl, Brad S. , Abramson, Jeremy S. , Winter, Jane N. , Gopal, Ajay K. , Schöder, Heiko , Zelenetz, Andrew D.

Mayo Clinic

Journal of Clinical Oncology | April 2, 2019 | Volume: 37 | Issue: 21 | Pages: 1790-1799

10.1200/jco.18.01994 | PMID 30939090 Get It

PURPOSE Alliance/CALGB 50303 (NCT00118209), an intergroup, phase III study, compared dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (DA-EPOCH-R) with standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) as frontline therapy for diffuse large B-cell lymphoma. PATIENTS AND METHODS Patients received six cycles of DA-EPOCH-R or R-CHOP. The primary objective was progression-free survival (PFS); secondary clinical objectives included response rate, overall survival (OS), and safety. RESULTS Between 2005 and 2013, 524 patients were registered; 491 eligible patients were included in the final analysis. Most patients (74%) had stage III or IV disease; International Prognostic Index (IPI) risk groups included 26% IPI 0 to 1, 37% IPI 2, 25% IPI 3, and 12% IPI 4 to 5. At a median follow-up of 5 years, PFS was not statistically different between the arms (hazard ratio, 0.93; 95% CI, 0.68 to 1.27; P = .65), with a 2-year PFS rate of 78.9% (95% CI, 73.8% to 84.2%) for DA-EPOCH-R and 75.5% (95% CI, 70.2% to 81.1%) for R-CHOP. OS was not different (hazard ratio, 1.09; 95% CI, 0.75 to 1.59; P = .64), with a 2-year OS rate of 86.5% (95% CI, 82.3% to 91%) for DA-EPOCH-R and 85.7% (95% CI, 81.4% to 90.2%) for R-CHOP. Grade 3 and 4 adverse events were more common ( P < .001) in the DA-EPOCH-R arm than the R-CHOP arm, including infection (16.9% v 10.7%, respectively), febrile neutropenia (35.0% v 17.7%, respectively), mucositis (8.4% v 2.1%, respectively), and neuropathy (18.6% v 3.3%, respectively). Five treatment-related deaths (2.1%) occurred in each arm. CONCLUSION In the 50303 study population, the more intensive, infusional DA-EPOCH-R was more toxic and did not improve PFS or OS compared with R-CHOP. The more favorable results with R-CHOP compared with historical controls suggest a potential patient selection bias and may preclude generalizability of results to specific risk subgroups.
Prevalence and Strains of Colorado Tick Fever Virus in Rocky Mountain Wood Ticks in the Bitterroot Valley, Montana
Williamson, Brandi N. , López, Job E. , Schwan, Tom G. , Fischer, Robert J. , Ebihara, Hideki

Mayo Clinic

Vector-Borne and Zoonotic Diseases | April 2, 2019 | Volume: 19 | Issue: 9 | Pages: 694-702

10.1089/vbz.2018.2407 | PMID 30939106 Get It

Intraoperative evaluation of cervical nerve root avulsion using ultra–high-frequency ultrasound system
Forte, Antonio J. , Oliver, Jeremie D. , McClain, Robert L., Murray, Peter M. , Clendenen, Steven R. , Murray, Peter, Forte, Antonio Jorge , Oliver, Jeremie D , Boczar, Daniel

Mayo Clinic

Case Reports in Plastic Surgery and Hand Surgery | April 2, 2019 | Volume: 6 | Issue: 1 | Pages: 43-46

10.1080/23320885.2019.1583569 | PMID 30989089 Get It

Expansile Traumatic Neuroma of the Intratemporal Facial Nerve
Feng, Yening , Patel, Neil , Burrows, Anthony M. , Lane, John I. , Carlson, Matthew L. , Raghunathan, Aditya , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Reports | April 1, 2019 | Volume: 80 | Issue: 01 | Pages: e10-e13

10.1055/s-0039-1685212 | PMID 30941279 Get It

Objectives To present a rare case of traumatic facial neuroma involving the geniculate ganglion and review relevant literature. Patient Thirty-year-old man. Intervention Microsurgical resection via combined mastoid-middle fossa approach with great auricular nerve interpositional graft. Main Outcome Measures Patient demographics and pre- and postoperative facial nerve function. Results A 30-year-old man with a reported history of prior Bell's palsy developed progressive complete (House–Brackmann VI) right facial paralysis following blunt trauma. Imaging was strongly suggestive of a geniculate ganglion hemangioma. As the patient had no spontaneous improvement in his poor facial function over the course of 9 months, he underwent resection of the facial nerve lesion with great auricular nerve graft interposition via a combined mastoid-middle fossa approach. Histopathology demonstrated disorganized fascicles, with axonal clustering reminiscent of sprouting/regeneration following trauma. No cellular proliferation or vascular malformation was present. Conclusion Traumatic facial nerve neuromas can occur following temporal bone trauma and can closely mimic primary facial nerve tumors. Akin to the management of geniculate ganglion hemangioma and schwannoma, preoperative facial function largely dictates if and when surgery should be pursued.
Response to letter by Samuels et al.
Brinjikji, Waleed , Albers, Gregory W. , Koch, Sebastian , Rabinstein, Alejandro A.

Mayo Clinic

International Journal of Stroke | April 1, 2019 | Volume: 14 | Issue: 4 | Pages: NP3-NP3

10.1177/1747493019840929 | PMID 30935348 Get It

Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference Intervals
Sandoval, Yader , Sexter, Anne, Gunsolus, Ian L. , Schulz, Karen , Apple, Fred S. , Smith, Stephen W.

Mayo Clinic

Circulation | April 1, 2019 | Volume: 139 | Issue: 14 | Pages: 1753-1755

10.1161/circulationaha.118.038284 | PMID 30933618 Get It

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Ismaila, Nofisat , Cheung, Matthew C. , Costello, Caitlin , Dhodapkar, Madhav V. , Kumar, Shaji , Lacy, Martha Q. , Lipe, Brea , Little, Richard F. , Nikonova, Anna S., Omel, James, Peswani, Namrata, Seth, Rahul , Vesole, David H. , Walker, Irwin , Whitley, Alexander C., Wildes, Tanya M. , Wong, Sandy W. , Martin, Tom, Lacy, Martha, Wildes, Tanya , Mıkhael, Joseph , Lipe, Brea , Nikonova, Anna, Prica, Anca A. , Raje, Noopur , Seth, Rahul

Mayo Clinic

Journal of Clinical Oncology | April 1, 2019 | Volume: 37 | Issue: 14 | Pages: 1228-1263

10.1200/jco.18.02096 | PMID 30932732 Get It

PURPOSE To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others. METHODS ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and some phase II studies published from 2005 through 2018. Outcomes of interest included survival, progression-free survival, response rate, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS The literature search identified 124 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS Evidence-based recommendations were developed for patients with multiple myeloma who are transplantation eligible and those who are ineligible and for patients with relapsed or refractory disease.
Frozen sections and complete resection in oral cancer surgery
Hinni, Michael L., Bussani, Rossana , Gatto, Annalisa, Bonini, Pierluigi, Giudici, Fabiola , Nata, Francesca Boscolo , Boscolo Nata, Francesca , Tirelli, Giancarlo , Fernández‐Fernández, Mario M.

Mayo Clinic

Oral Diseases | April 1, 2019 | Volume: 25 | Issue: 5 | Pages: 1309-1317

10.1111/odi.13101 | PMID 30933401 Get It

AbstractObjectivesAlthough the reliability of frozen sections for the intraoperative assessment of complete tumour excision has been established, the best location for collection and the impact of the type of sampling are still debated. We retrospectively investigated the reliability of frozen sections when collected from the surgical bed as tissue strips representative of the whole superficial margin and as a bowl of tissue underlying the resection site for deep margin, and the possibility of relying on frozen section negativity to consider resections complete.Materials and MethodsFrozen section reliability was calculated by comparing histology before and after formalin embedding and then categorised by sampling type, in 182 patients undergoing transoral resection of oral cancer.ResultsComparing frozen and permanent histology, sensitivity, specificity and accuracy were 69%, 98% and 96%, respectively; categorisation by sampling type failed to produce statistically significant differences. Based on frozen section negativity after formalin embedding, complete resections were obtained in 91.7% of patients with multiple‐strip and bowl frozen sections.ConclusionFrozen sections collected as tissue strips and bowl are as reliable as point sampling in the intraoperative guidance of surgical resections. They effectively provide for margin enlargement, thereby increasing the surgeon's confidence that negative margins are clear.
Breaking tolerance with engineered class I antigen-presenting molecules
Parks, Christopher A. , Henning, Kalli R., Hansen, Michael J. , Keulen, Virginia P. Van , Reed, Brendan , Schrum, Adam G. , Gil, Diana , Kranz, David M. , Bordner, Andrew J., Barry, Michael A. , Pease, Larry R. , Pavelko, Kevin D. , Reed, Brendan K, Schrum, Adam G , Barry, Michael A , Stone, Jennifer D.

Mayo Clinic

Proceedings of the National Academy of Sciences | April 1, 2019 | Volume: 116 | Issue: 8 | Pages: 3136-3145

10.1073/pnas.1807465116 | PMID 30728302 Get It

Significance Provision of sufficient activating signals can drive self-tolerant T cells to cross-react on self-peptide-MHC in a breakdown of tolerance. This approach has been applied in the development of heteroclitic peptide vaccines, which retain sufficient similarity to self to allow reactivation of effector cells on unaltered self-epitopes but require detailed knowledge about the behavior of individual altered self-peptide antigens. We designed altered-self MHC mutant antigen-presenting molecules to drive CTL capable of cross-reacting on self-peptide-MHC and demonstrate the breaking of self-tolerance to defined and undefined self-antigens. These findings bear particular importance in the field of cancer immunotherapy in which breaking tolerance to weakly antigenic cancer-associated antigens is fundamental to vaccination strategies.
Dental root abnormalities in four children with PHACE syndrome
Youssef, Molly J. , Siegel, Dawn H. , Chiu, Yvonne E. , Drolet, Beth A. , Hodgson, Brian D. , Chiu, Yvonne E

Mayo Clinic

Pediatric Dermatology | April 1, 2019 | Volume: 36 | Issue: 4 | Pages: 505-508

10.1111/pde.13818 | PMID 30933385 Get It

AbstractPHACE(S) syndrome is a condition characterized by posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects, eye abnormalities, sternal cleft, and supraumbilical raphe. We present four children with PHACE(S) syndrome who have absence of or severe malformation of the roots of their permanent first molars (PFMs). Root abnormalities in the children's molars were bilateral and not restricted to the segments affected by cutaneous hemangioma. The reason for root abnormalities is unknown, but given the rarity of these findings in healthy children, it is likely an additional dental manifestation of PHACE syndrome. The absence of functional roots in the PFMs can result in significant consequences. Therefore, we recommend a panoramic dental radiograph during transitional dentition for children with PHACE syndrome to screen for dental root abnormalities.